CYTOKINETICS, INCORPORATED |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.4 USD | -1.34% |
|
-0.44% | -23.27% |
| 04:51pm | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
| 05-08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |
